<DOC>
	<DOC>NCT00808249</DOC>
	<brief_summary>The purpose of this research study is to determine whether AstraZeneca's drug AZD7325 is safe and effective in the treatment of generalized anxiety disorder.</brief_summary>
	<brief_title>AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Signed informed consent before any studyrelated procedures start. The patient is previously diagnosed with Generalized Anxiety Disorder. The patient has a HADSA (anxiety) score â‰¥10 at both screening and randomization. Patient has a lifetime history of schizophrenia or other psychotic disorders Patient has a history of seizures or seizure disorder. Patient is pregnant or breast feeding. Patient has received electroconvulsive treatment (ECT) in the past.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Generalized Anxiety Disorder</keyword>
	<keyword>GAD</keyword>
	<keyword>Anxiety</keyword>
</DOC>